Zobrazeno 1 - 7
of 7
pro vyhledávání: '"M. Liza Lindenberg"'
Autor:
Wai-Kit Lee, M. Liza Lindenberg, Esther Mena Gonzalez, Peter Choyke, Kevin G. King, Raghunandan Vikram, Vinnay A. Duddalwar
Publikováno v:
Société Internationale d’Urologie Journal, Vol 3, Iss 6, p 6 (2022)
Imaging plays a central role in the contemporary multidisciplinary management of renal cell carcinoma. This article provides an overview of the current imaging modalities, including ultrasound, computed tomography, multiparametric magnetic resonanc
Externí odkaz:
https://doaj.org/article/4389fba1ce8e43809ea82e68dfb4989b
Autor:
Barry C. Johnson, Esther Mena, Nancy Moore, Cecilia Monge Bonilla, Frank I. Lin, Lamin Juwara, James H. Doroshow, Geraldine O'Sullivan Coyne, Matthew M. Ames, Matthew P. Goetz, Alice P. Chen, M. Liza Lindenberg, Larry Rubinstein, S. Kummar, Howard Streicher, Renee M. McGovern, Joseph M. Covey, Peter L. Choyke, Joel M. Reid, Richard Piekarz, Rachel Bishop, Naoko Takebe, Jerry M. Collins
Publikováno v:
Oncotarget
Background: Differential responses to tamoxifen may be due to inter-patient variability in tamoxifen metabolism into pharmacologically active Z-endoxifen. Z-endoxifen administration was anticipated to bypass these variations, increasing active drug l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::789da74afa192fbe2f88f4607eae46ca
http://europepmc.org/articles/PMC7899551
http://europepmc.org/articles/PMC7899551
Autor:
Stephen Adler, Colin R. Young, Peter L. Choyke, M. Liza Lindenberg, Paula M. Jacobs, Jerry M. Collins, Shivaani Kummar, Janet F. Eary, Karen A. Kurdziel, Esther Mena
Publikováno v:
Journal of Nuclear Medicine. 60:492-496
In preclinical studies, 5-fluoro-2′-deoxycytidine (FdCyd), an inhibitor of DNA methyltransferase and DNA hypermethylation, has shown treatment efficacy against multiple malignancies by suppressing epigenetic hypermethylation in tumor cells. Several
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39c1b111fdc16d28e20d65cc4777d787
https://doi.org/10.2967/jnumed.118.216994
https://doi.org/10.2967/jnumed.118.216994
Autor:
Deborah Citrin, Ethan Bergvall, Paula M. Jacobs, Yolanda McKinney, Stephanie Harmon, James L. Gulley, Peter L. Choyke, Baris Turkbey, Sherif Mehralivand, Ravi A. Madan, Martin G. Pomper, Stephen Adler, Joanna H. Shih, M. Liza Lindenberg, Anna Couvillon, Esther Mena, Ronnie C. Mease
Publikováno v:
Journal of Nuclear Medicine. 59:1665-1671
The purpose of this study was to compare the diagnostic performance of 18F-DCFBC PET/CT, a first-generation 18F-labeled prostate-specific membrane antigen (PSMA)-targeted agent, and 18F-NaF PET/CT, a sensitive marker of osteoblastic activity, in a pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8312aaa975f9ea8cbdd0cdecfa5f88d0
https://doi.org/10.2967/jnumed.117.207373
https://doi.org/10.2967/jnumed.117.207373
Autor:
Colin R, Young, Stephen, Adler, Janet F, Eary, M Liza, Lindenberg, Paula M, Jacobs, Jerry, Collins, Shivaani, Kummar, Karen A, Kurdziel, Peter L, Choyke, Esther, Mena
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 60(4)
In preclinical studies, 5-fluoro-2′-deoxycytidine (FdCyd), an inhibitor of DNA methyltransferase and DNA hypermethylation, has shown treatment efficacy against multiple malignancies by suppressing epigenetic hypermethylation in tumor cells. Several
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c214608f259cd626aa5f9b90c78f4b75
https://pubmed.ncbi.nlm.nih.gov/30389817
https://pubmed.ncbi.nlm.nih.gov/30389817
Autor:
Stephanie A, Harmon, Ethan, Bergvall, Esther, Mena, Joanna H, Shih, Stephen, Adler, Yolanda, McKinney, Sherif, Mehralivand, Deborah E, Citrin, Anna, Couvillon, Ravi A, Madan, James L, Gulley, Ronnie C, Mease, Paula M, Jacobs, Martin G, Pomper, Baris, Turkbey, Peter L, Choyke, M Liza, Lindenberg
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 59(11)
The purpose of this study was to compare the diagnostic performance of (18)F-DCFBC PET/CT, a first-generation (18)F-labeled prostate-specific membrane antigen (PSMA)–targeted agent, and (18)F-NaF PET/CT, a sensitive marker of osteoblastic activity,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8751bb44f4ff1f8b72f1dadcc61c5d30
https://pubmed.ncbi.nlm.nih.gov/29602821
https://pubmed.ncbi.nlm.nih.gov/29602821
Autor:
Stephen Adler, M. Liza Lindenberg, Joanna Shih, Ravi A. Madan, Sherif Mehralivand, Ethan Bergvall, Stephanie Harmon, James L. Gulley, W. L. Dahut, Peter L. Choyke, Baris Turkbey, Esther Mena
Publikováno v:
Cancer Research. 78:3671-3671
Purpose: The purpose of this study was to compare the spatial colocalization of prostate-specific membrane antigen (PSMA) targeting agent 18F-DCFBC PET/CT, a marker which demonstrates correlation with tumor aggressiveness, and 18F-NaF PET/CT, a marke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b936d72e00715d5487c99e6a752b94d
https://doi.org/10.1158/1538-7445.am2018-3671
https://doi.org/10.1158/1538-7445.am2018-3671